SEIE - ETF AI Analysis

Top Page

SEI Select International Equity ETF (SEIE)

Rating:63Neutral

Price Target:―

SEIE, the SEI Select International Equity ETF, has a solid overall rating driven mainly by strong, diversified holdings in global financials and healthcare, such as HSBC, AstraZeneca, Novartis, and Barclays, which benefit from healthy financial performance, positive earnings calls, and generally reasonable valuations. Some positions like ING Groep and ArcelorMittal face cash flow or revenue volatility challenges that may weigh on the fund, and there is a notable concentration in financial and pharmaceutical companies, which can increase sector-specific risk if those industries face downturns.

Positive Factors

Broad International Diversification

The fund spreads its investments across many countries, with notable exposure to Japan, the UK, and several major European markets, which helps reduce reliance on any single economy.

Balanced Sector Mix

Holdings are spread across financials, industrials, consumer, health care, and other sectors, which can help smooth out performance when one industry is struggling.

Solid Recent Performance

The ETF has shown steady gains over the past month and quarter, indicating positive recent momentum.

Negative Factors

Moderately High Expense Ratio

The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees each year.

Heavy Tilt Toward Financials

A large share of the portfolio is in financial stocks, so the fund may be more sensitive to problems in the banking and financial sector.

Mixed Performance Among Top Holdings

While several leading positions have performed well, a few key holdings have shown weaker or negative returns, which can drag on overall results.

SEIE vs. SPDR S&P 500 ETF (SPY)

AUM953.84M

RegionDeveloped Markets

Expense Ratio0.50%

Beta0.73

IssuerSEI

Inception DateOct 10, 2024

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume78,124

30 Day Avg. Volume120,267

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

37.11

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering332

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SEIE Summary

The SEI Select International Equity ETF (SEIE) invests in a wide mix of companies outside the U.S., aiming to track the overall international stock market rather than a single index. It spreads money across many countries like Japan, the UK, and France, and across sectors such as financials, industrials, and healthcare. Well-known holdings include HSBC Holdings and Novartis. Someone might invest in SEIE to diversify beyond U.S. stocks and seek long-term growth from global markets. A key risk is that international stock prices can be volatile and may rise or fall with global economic and currency changes.

How much will it cost me?The SEI Select International Equity ETF (SEIE) has an expense ratio of 0.5%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average because it is actively managed, which typically involves more research and decision-making compared to passively managed funds that track an index.

What would affect this ETF?The SEI Select International Equity ETF (SEIE) could benefit from positive trends in developed markets outside the U.S., such as economic growth or technological advancements, particularly in sectors like financials and healthcare, which have significant weight in the fund. However, challenges like rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact its performance, especially for top holdings like HSBC and Novartis. Diversification across sectors and countries helps mitigate some risks but does not eliminate exposure to global economic uncertainties.

SEIE Top 10 Holdings

SEIE leans heavily on big European banks and global drugmakers, and lately that mix has been working. HSBC and ING are helping steer returns higher, while Barclays and Standard Chartered are more of a mixed bag, occasionally tapping the brakes. On the health care side, steady strength from GlaxoSmithKline, Novartis, Roche, and AstraZeneca gives the fund a solid defensive backbone. Murata Manufacturing and ArcelorMittal add a dash of cyclical and industrial punch. Overall, it’s a developed-markets, ex-U.S. story with a clear tilt toward financials and pharma.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
HSBA	HSBC Holdings	1.71%	$16.22M	£202.74B	35.68%	80 Outperform
GSK	GlaxoSmithKline	1.40%	$13.33M	£81.32B	34.41%	77 Outperform
NOVN	Novartis AG	1.37%	$13.06M	CHF230.97B	25.96%	80 Outperform
6981	Murata Manufacturing Co	1.19%	$11.31M	¥6.73T	28.37%	77 Outperform
ASML	ASML Holding NV	1.19%	$11.31M	€450.59B	80.13%	76 Outperform
INGA	ING GROEP	1.08%	$10.25M	€63.77B	20.39%	61 Neutral
AZN	AstraZeneca	1.04%	$9.94M	$295.20B	19.89%	80 Outperform
STAN	Standard Chartered	1.02%	$9.69M	£34.46B	35.30%	77 Outperform
ROG	Roche Holding AG	0.95%	$9.01M	CHF256.31B	21.75%	73 Outperform
MT	ArcelorMittal	0.92%	$8.74M	€33.27B	52.57%	73 Outperform

SEIE Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

34.05

Negative

100DMA

32.70

Negative

200DMA

31.03

Positive

Market Momentum

MACD

-0.40

Positive

RSI

30.02

Neutral

STOCH

16.81

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SEIE, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 34.48, equal to the 50-day MA of 34.05, and equal to the 200-day MA of 31.03, indicating a neutral trend. The MACD of -0.40 indicates Positive momentum. The RSI at 30.02 is Neutral, neither overbought nor oversold. The STOCH value of 16.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SEIE.

SEIE Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
SEIE	―	―	$953.84M	0.50%	63 Neutral
DFSI	―	―	$974.24M	0.24%	64 Neutral
FYLD	―	―	$594.27M	0.59%	60 Neutral
AVSD	―	―	$415.02M	0.23%	65 Neutral
TXUE	―	―	$411.92M	0.65%	62 Neutral
RFDI	―	―	$145.69M	0.83%	68 Neutral

Performance Comparison

SEIE

SEI Select International Equity ETF

32.36

5.98

22.67%

DFSI

Dimensional International Sustainability Core 1 ETF

―

FYLD

Cambria Foreign Shareholder Yield ETF

―

AVSD

Avantis Responsible International Equity ETF

―

TXUE

Thornburg International Equity ETF

―

RFDI

First Trust Riverfront Dynamic Developed International ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents